Factors associated with emergency department (ED) attendance during last month of life

the ONA take:

According to a new study published in the Journal of Clinical Oncology, researchers from King's College London Cicely Saunders Institute in London, United Kingdom, have identified demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer during the final month of life.

For the study, researchers sought to investigate factors associated with emergency department attendance by patients with cancer during the last month of their lives. They analyzed data from five electronic databases and identified 30 studies that investigated emergency department attendance at the end of the lives of patients with cancer.

The studies included nearly 1.2 million patients from five countries and reported 13 environmental, five clinical, and three demographic factors in total.

Results showed an increased risk of emergency department attendance was associated with black race (OR = 1.45; 95% CI: 1.40 - 1.50), male gender (OR = 1.24; 95% CI: 1.19 - 1.29), having lung cancer (OR = 1.17; 95% CI: 1.10 - 1.23), and those of low socioeconomic status (OR = 1.15; 95% CI: 1.10 - 1.19).

Patients receiving palliative care were less likely to have an emergency department visit during the last month of life (OR = 0.43; 95% CI: 0.36 - 0.51).

For 80% of colorectal cancers, Janus kinase (JAK) inhibitors may be effective
Demographic and environmental factors associated with an increased risk of emergency department visits by patients with cancer.
The authors aimed to explore factors associated with emergency department (ED) attendance by patients with cancer in their last month of life. They identified demographic (men; black race), clinical (lung cancer), and environmental (low SES; no palliative care) factors associated with an increased risk of ED attendance by patients with cancer in their last month of life.
READ FULL ARTICLE From Mdlinx
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs